Daniel

[Daniel @DanielAlbinn]

"...The chief difference between a fool and a wise man is that the wise man learns from his mistakes, while the fool never does." - P.Fisher

[Daniel @DanielAlbinn]

@suspendedJoey @MDollares Är nedan verkligen pure BS?

[Daniel @DanielAlbinn]

@suspendedJoey @MDollares Anomalin jag själv inte kunnat få svar på rörande kombo med MTX är att (i) MIRROR studien du refererar till exkluderas patienter med eGFR < 40 mL (i princip samtliga patienter med moderat form av CKD). Och (ii) mig veterligen finns det ett nära samband mellan svår gikt och CKD.

[Daniel @DanielAlbinn]

@suspendedJoey @MDollares Inte givet att administrera MTX i en patientpopulation med svår gikt.

[Trung Phan @TrungTPhan]

At 40, Jim Simons left a famed math career to launch the most successful hedge fund ever: Renaissance Tech.

Even though it only won 51% of trades, the fund made 66%/yr for 30yrs (Simons worth = $25B). It's a story of genius, but also of how hard it is to beat markets.

THREAD🧵

[Daniel @DanielAlbinn]

@timeinmarket @HandelsCapital Kul Ludwig. Många alumner här på Twitter och i Sthlm som gått samma skola. Keep it up! 🙌🏻

[Daniel @DanielAlbinn]

Bristol Myers Squibb - U.S. Food and Drug Administration Approves Bristol Myers Squibb’s and bluebird bio’s Abecma (idecabtagene vicleucel), the First Anti-BCMA CAR T Cell Therapy for Relapsed or Refractory Multiple Myeloma https://t.co/q3YokRPEVI

[Daniel @DanielAlbinn]

@danne_w +1 på den!

[Arsalan Arif @arsalanarif]

"Gene therapy is at an inflection point:" Kathy High on her new perch at AskBio and the field's future

by @Jasonmmast

https://t.co/ZpAQGNHbah

[Eric Topol @EricTopol]

Some encouraging new data/analysis supports benefit of convalescent plasma for severe #covid19
https://t.co/H1s7UgJATz by @AmyDMarcus
https://t.co/EDVbGIlwsu

[Mostly Borrowed Ideas @borrowed_ideas]

1/ MEGA THREAD: Long $ISRG

ISRG has been an incredible compounder ever since its IPO back in 2000. It's a pure-play in robotic surgery.

Robotic surgery penetration is still just ~2.5% of worldwide surgery procedures. It's still Day 1 here!

Let's start with some history.

[leveredlloyd @leveredlloyd]

Negative news ain’t gonna stop these algo boys

[Daniel @DanielAlbinn]

@m64592954 Intressant observandum, man ska dock skilja på kausalitet och korrelation..

[Meg Tirrell @megtirrell]

NEWS: Gilead releases first remdesivir data, from 53 patients on compassionate use. Says treatment resulted in clinical improvement in 68% of patients. Note no control group; clinical trial results coming soon https://t.co/55C4tQR687 #COVID19

[Daniel @DanielAlbinn]

@m64592954 Tack för att du delar

[Daniel @DanielAlbinn]

@InveSWEster Jesus

[Daniel @DanielAlbinn]

@o_markusson 🙌🏼🙌🏼🙌🏼

[NEJM @NEJM]

In this report, investigators in Wuhan, China, describe the spectrum of Covid-19 illness in children under the age of 16 years. #COVID19 #SARSCoV2

[Daniel @DanielAlbinn]

@Psychocandy_74 Hehe

[Daniel @DanielAlbinn]

@dividendblower Bra skrivet! Om +5 år tror jag situation ser annorlunda ut. Över tid kommer Talenom även bli ett ERP-provider. Men vad vet jag..